Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2008
10/28/2008CA2283507C Process for preparing pyrazole derivatives
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008126898A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008125833A1 Pharmaceutical compounds
10/23/2008WO2008125811A1 N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
10/23/2008WO2008125599A1 2-carboxy thiophene derivatives as anti-viral agents
10/23/2008WO2008125570A1 New bradykinin b1 antagonists
10/23/2008WO2008096127A3 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008US20080262073 Pyrrolic Derivatives with Histone Deacetylase Inhibitory Activity
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080261996 Substituted propiolic acid amides and their use for producing drugs
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261945 Compounds Having Activity at Nk3 Receptor and Uses Thereof in Medicine
10/23/2008US20080261944 Indole Derivatives as Antiviral Agents
10/23/2008CA2683619A1 Pharmaceutical compounds
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008CA2660201A1 Organic compounds
10/22/2008EP1982978A1 Pyridone derivative and herbicide
10/22/2008EP1981882A1 Amide substituted quinolines
10/22/2008EP1981879A1 Amino indazole derivatives
10/22/2008EP1981878A1 Indazole heteroaryl derivatives
10/22/2008EP1981877A1 N-hydroxyacrylamide compounds
10/22/2008EP1981876A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
10/22/2008EP1981874A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981864A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/22/2008EP1981855A2 Substituted bis-amide metalloprotease inhibitors
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981497A2 Use of substituted 2-imidazole of imidazoline derivatives
10/22/2008EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors
10/22/2008EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291925A Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
10/22/2008CN101291924A Isoindole-imide compounds and compositions comprising and methods of using the same
10/22/2008CN101291918A Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
10/22/2008CN100427483C Anthranilic acid amide derivatives and their pharmaceutical use
10/22/2008CN100427479C Photochromic perfluoro cyclopentene diaryl ethylene schiff base compound, and its preparing method and use
10/22/2008CN100427478C Mulit-wavelength optical storage medium and its preparation method and special production raw material
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/16/2008WO2008124703A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008WO2008124083A2 Aurora kinase modulators and method of use
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008122356A1 Cardiovascular agents
10/16/2008WO2008122352A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp)
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255220 Therapeutic Substituted Gamma Lactams
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255197 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
10/16/2008US20080255183 N-[(3,5-dimethylisoxazol-4-yl)carbonyl]-3-{5-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]thiophen-2-yl}-L-alanine; treatment of solid tumors
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255152 Diaryl ethers as opioid receptor antagonists
10/16/2008US20080255143 Inhibitors of Akt Activity
10/16/2008US20080255142 Substituted Piperidine Derivatives as Somatostatin Sst1 Receptor Antagonists
10/16/2008US20080255137 N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255120 Substituted 2,5-heterocyclic derivatives
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide
10/16/2008CA2683434A1 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008CA2682875A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1980559A1 Cardiovascular agents
10/15/2008EP1979345A2 Novel pyridine derivatives
10/15/2008EP1979338A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
10/15/2008EP1979328A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979327A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979326A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
10/15/2008EP1979315A2 Methods for treating hepatitis c
10/15/2008EP1979314A2 Indole sulfonamide modulators of progesterone receptors
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1173432B9 Piperidine-indole compounds having 5-ht6 affinity
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287728A Novel high affinity thiophene-based and furan-based kinase ligands
10/15/2008CN101287727A Novel high affinity quinoline-based kinase ligands
10/15/2008CN101287725A DNA-PK inhibitors
10/15/2008CN101287707A 激酶抑制剂 Kinase inhibitors
10/15/2008CN101284828A Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds
10/15/2008CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 523